ZBiotics, founded in 2016 and based in San Francisco, California, is a synthetic biology company focused on bioengineering probiotic bacteria for nutraceutical applications. Their core mission is to enhance human health through innovative genetic engineering. In 2019, they launched the world's first genetically engineered probiotic designed to break down acetaldehyde, a toxic byproduct of alcohol. ZBiotics continues to develop a range of engineered probiotics aimed at addressing various consumer health needs.
Notable figures associated with ZBiotics include its founding team of scientists and biotech experts. The company has garnered attention from prominent investors in the biotech and health sectors. Key achievements include the successful market introduction of their groundbreaking probiotic product and ongoing advancements in their product pipeline. ZBiotics' impact lies in pioneering safe and effective genetic engineering solutions that promote better health and well-being.
